Two former pharma execs first to be charged in generic price-fixing probe

(Ed Silverman for STAT)

Two former Heritage Pharmaceuticals executives were accused by federal authorities on Wednesday of conspiring with rivals to fix prices for a widely used antibiotic, the first criminal charges to stem from a two-year investigation into price collusion among generic drug makers. Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.